Andy Smith

Andy Smith

Investitore di Private Equity presso Oak HC/FT Management Co. LLC

Finance
Consumer Services

Profilo

Andy Smith, a Principal at Oak HC/FT, joined the firm in 2017 and focuses on growth equity and early-stage venture opportunities in healthcare.
Andy currently serves as a Board Observer at August Bioservices, Curana Health, Infusion for Health, Maven and Truepill.
Andy is also actively involved with DispatchHealth, Komodo Health, Modern Age, Precision for Medicine, Rubicon Founders and WithMe Health.
His prior investments include Olive and GeneDx Holdings (NASDAQ: WGS).
Prior to joining Oak HC/FT, Andy was an Associate at Safeguard Scientifics where he focused on technology-driven businesses in healthcare.
Prior to this, Andy was an Analyst at Credit Suisse where he focused on the healthcare services sector.
Andy received a Bachelor of Science degree from the University of Virginia’s McIntire School of Commerce.

Posizioni attive di Andy Smith

SocietàPosizioneInizio
Investitore di Private Equity 01/04/2017
Tutte le posizioni attive di Andy Smith

Precedenti posizioni note di Andy Smith

SocietàPosizioneFine
SAFEGUARD SCIENTIFICS, INC. Corporate Officer/Principal 01/03/2017
Credit Suisse /Private Banking Division North America/ Corporate Officer/Principal 01/03/2015
Vedi nel dettaglio l'esperienza di Andy Smith

Formazione di Andy Smith

University of Virginia Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Andy Smith

Relazioni

100 +

Relazioni di 1° grado

4

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
SAFEGUARD SCIENTIFICS, INC.

Finance

Aziende private2

Finance

Credit Suisse /Private Banking Division North America/

Finance

Vedi le connessioni aziendali